Quarterly report [Sections 13 or 15(d)]

Investments

v3.25.3
Investments
9 Months Ended
Sep. 27, 2025
Investments, Debt and Equity Securities [Abstract]  
Investments
Note 8 : Investments
Short-term Investments
Short-term investments include marketable debt investments in corporate debt, government debt, and financial institution instruments, and are recorded within cash and cash equivalents and short-term investments on the Consolidated Condensed Balance Sheets. Government debt includes instruments such as non-U.S. government bills and bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as fixed- and floating-rate bonds, money market fund deposits, and time deposits. As of September 27, 2025 and December 28, 2024, substantially all time deposits were issued by institutions outside the US.
For certain of our marketable debt investments, we economically hedge market risks at inception with a related derivative instrument or the marketable debt investment itself is used to economically hedge currency exchange rate risk from remeasurement. These hedged investments are reported at fair value with gains or losses from the investments and the related derivative instruments recorded in interest and other, net. The fair value of our economically hedged marketable debt investments was $19.1 billion as of September 27, 2025 ($13.5 billion as of December 28, 2024). For hedged investments still held at the reporting date, we recorded net losses of $47 million in the third quarter of 2025 and net gains of $416 million in the first nine months of 2025 (net gains of $406 million in the third quarter of 2024 and net gains of $195 million in the first nine months of 2024).
Our remaining unhedged marketable debt investments are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss) and realized gains or losses recorded in interest and other, net. The adjusted cost of our unhedged investments was $6.8 billion as of September 27, 2025 ($5.2 billion as of December 28, 2024), which approximated the fair value at these dates.
The fair values of marketable debt investments, by contractual maturity, as of September 27, 2025, were as follows:
(In Millions) Fair Value
Due in 1 year or less
$ 7,452 
Due in 1 – 2 years
7,233 
Due in 2 – 5 years
6,926 
Due after 5 years
188 
Instruments not due at a single maturity date1
4,099 
Total $ 25,898 
1 "Instruments not due at a single maturity date" is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.
Equity Investments
(In Millions) Sep 27, 2025 Dec 28, 2024
Marketable equity investments1
$ 572  $ 848 
Non-marketable equity investments
8,095  4,535 
Total $ 8,667  $ 5,383 
1 Most of our marketable equity investments are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. Certain of the trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.
The components of gains (losses) on equity investments, net for each period were as follows:
  Three Months Ended Nine Months Ended
(In Millions)
Sep 27, 2025 Sep 28, 2024 Sep 27, 2025 Sep 28, 2024
Unrealized gains (losses) on marketable equity investments $ 116  $ (198) $ (234) $ (168)
Unrealized gains (losses) on non-marketable equity investments1
17  —  490  48 
Impairment charges on non-marketable equity investments (76) (110) (232) (269)
Unrealized gains (losses) on equity investments, net 57  (308) 24  (389)
Realized gains (losses) on sales of equity investments, net 164  149  587  315 
Gains (losses) on equity investments, net $ 221  $ (159) $ 611  $ (74)
1 Unrealized gains (losses) on non-marketable investments includes observable price adjustments and our share of equity method investee gains (losses) and certain distributions.
In the first nine months of 2025, we recognized upward observable price adjustments for our non-marketable equity investments of $486 million within gains (losses) on equity investments, net, of which $396 million related to a single investee.
Altera
In the third quarter of 2025, we closed the sale of Altera and retained a 49% interest in the business (refer to "Note 9: Divestitures" within Notes to Consolidated Condensed Financial Statements). The carrying value of our non-marketable equity investment in Altera is classified within equity investments in the Consolidated Condensed Balance Sheets and was $3.2 billion as of September 27, 2025.
We provide semiconductor wafer manufacturing services to Altera, a related party, in accordance with a wafer manufacturing and sale agreement. Additionally, and in connection with the divestiture, we will be reimbursed for costs that we incur on behalf of Altera for certain corporate services delivered under a transition services agreement, which may include information technology, finance, supply chain, and other services provided on an interim basis.